Prognostic factors in stage T1 grade 3 bladder cancer survival: The role of G1-S modulators (p53, p21Waf1, p27kip1, cyclin D1, and cyclin D3) and proliferation index (ki67-MIB1)

被引:102
作者
Lopez-Beltran, A
Luque, RJ
Alvarez-Kindelan, J
Quintero, A
Merlo, F
Carrasco, JC
Requena, MJ
Montironi, R
机构
[1] Reina Sofia Univ Hosp, Dept Pathol, Cordoba, Spain
[2] Univ Cordoba, Sch Med, E-14071 Cordoba, Spain
[3] Jaen Univ Hosp, Dept Pathol, Jaen, Spain
[4] Reina Sofia Univ Hosp, Urol Serv, Cordoba, Spain
[5] Reina Sofia Univ Hosp, Biomed Res Unit, Cordoba, Spain
[6] Polytech Univ Marche Reg Ancona, Umberto Hosp 1, Inst Pathol Anat & Histopathol, I-60020 Ancona, Italy
关键词
bladder cancer; survival; cyclin D3; cyclin D1; p27kip1; tumor size; ki67; p53; p21Waf1; stage T1;
D O I
10.1016/j.eururo.2003.11.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the prognostic value of a subset of regulators of the transition from G1-to-S phase of cell cycle in stage T1 grade 3 bladder cancers. Methods: Fifty-one such cases were investigated to determine the significance on patient's survival of p53, p21 Waf1, p27Kip1, Cyclin D1, Cyclin D3, and ki67-MIB1 (proliferation index). The statistical analysis included Kaplan-Meier methodology with Log-rank test and Cox' proportional hazard analysis. Results: Tumor size (p = 0.0034), and the labeling index of ki67-MIb1 (p = 0.0034), p53 (p = 0.0332), p27kip1 (p = 0.0059) and Cyclin D1 (p = 0.0103) were associated to disease-free survival. Progression-free survival was related to tumor size (p < 0.0001), ki67 (p = 0.0163), p53 (p = 0.0041), p27kip1 (p = 0.0161), Cyclin D1 (p < 0.0001) and Cyclin D3 (p < 0.0001). Patient's overall survival was associated to Cyclin D3 (p < 0.0001), p53 (p = 0.0017), p21Waf1 (p = 0.0142), Cyclin D1 (p < 0.0001), ki67-MIB1 (p = 0.0450), and tumor size (p = 0.0296). Down-regulation of p27kip1 and Cyclin D3 over-expression (disease-free), over-expression of p53, Cyclin D1 and Cyclin D3 (progression-free), and over-expression of Cyclin D3 (overall survival) were independent predictors by Cox's multivariate analysis. Down-regulation of p27kip1 (p < 0.001, R.R. 0.997, 95%C.I. 0.995-0.999), and over-expression of Cyclin D1 (p < 0.001, R.R. 1.009, 95%C.I. 1.004-1.014) and Cyclin D3 (p = 0.005, R.R. 1.013, 95%C.I. 1.004-1.022) were the main independent predictors. Conclusion: Down-regulation of p27kip1 and over-expression of Cyclin D1 and Cyclin D3 might be relevant predictors of survival in stage T1 grade 3 bladder cancers, thus selecting a group of patients at higher risk of malignant behavior. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 32 条
[1]  
Bartkova J, 1996, INT J CANCER, V65, P323, DOI 10.1002/(SICI)1097-0215(19960126)65:3<323::AID-IJC8>3.0.CO
[2]  
2-1
[3]   Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer:: A formal meta-analysis of comparative studies on recurrence and toxicity [J].
Böhle, A ;
Jocham, D ;
Bock, PR .
JOURNAL OF UROLOGY, 2003, 169 (01) :90-95
[4]   Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin [J].
Brake, M ;
Loertzer, H ;
Horsch, R ;
Keller, H .
JOURNAL OF UROLOGY, 2000, 163 (06) :1697-1701
[5]  
Filipits M, 2002, CLIN CANCER RES, V8, P729
[6]  
Fradet Y, 2000, Curr Opin Urol, V10, P441, DOI 10.1097/00042307-200009000-00013
[7]  
Greene FL., 2002, AJCC CANC STAGING HD, V6th
[8]   Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters [J].
Hedberg, Y ;
Roos, G ;
Ljungberg, B ;
Landberg, G .
ACTA ONCOLOGICA, 2002, 41 (02) :175-181
[9]   Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? [J].
Herr, HW ;
Sogani, PC .
JOURNAL OF UROLOGY, 2001, 166 (04) :1296-1299
[10]   Cell cycle regulators in bladder cancer: A multivariate survival study with emphasis on p27Kip1 [J].
Korkolopoulou, P ;
Christodoulou, P ;
Konstantinidou, AE ;
Thomas-Tsagli, E ;
Kapralos, P ;
Davaris, P .
HUMAN PATHOLOGY, 2000, 31 (06) :751-760